Evidence map›Paper›PMID 37242607›Full record

ArticlePharmaceutics2023

In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four

Awid Adnan, Andrew M Borman, Zoltán Tóth, Lajos Forgács, Renátó Kovács, Dávid Balázsi, Bence Balázs, Gergely Udvarhelyi, Gábor Kardos, László Majoros

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  4. Unveiling the mechanisms of synthetic compounds againstCurrent research in pharmacology and drug discovery · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Awid AdnanDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Andrew M BormanUK National Mycology Reference Laboratory, UK Health Security Agency, Science Quarter, Southmead Hospital, Bristol BS10 5NB, UK.ORCID 0000-0003-0585-5721
Zoltán TóthDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Lajos ForgácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Renátó KovácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0003-3946-2424
Dávid BalázsiDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Bence BalázsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Gergely UdvarhelyiDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Gábor KardosDepartment of Metagenomics, University of Debrecen, 4032 Debrecen, Hungary.
László MajorosDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
University of Debrecen · HUUniversity of Exeter · GB

Funding

Hungarian National Research, Development and Innovation Office NKFIH FK138462
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chitin synthase inhibitorechinocandinssynergismtime–kill methodology

Identifiers

PMID37242607
PMCPMC10222763
OpenAlexW4367627889

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.